Header cover image

U.K. (FTSE) Healthcare Sector Analysis

UpdatedDec 03, 2023
DataAggregated Company Financials
Companies118
  • 7D0.2%
  • 3M-2.7%
  • 1Y-6.2%
  • YTD-8.6%

In the last week, the Healthcare industry is flat overall, with Genus standing out by going down 8.7%. As for the longer term, the industry has declined 6.2% in the last year. As for the next few years, earnings are expected to grow by 18% per annum.

Sector Valuation and Performance

Has the U.K. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 03 Dec 2023UKĀ£261.8bUKĀ£84.0bUKĀ£10.7b39x24.6x3.1x
Tue, 31 Oct 2023UKĀ£263.7bUKĀ£86.0bUKĀ£10.3b40.1x25.6x3.1x
Thu, 28 Sep 2023UKĀ£282.3bUKĀ£86.2bUKĀ£10.3b39.9x27.3x3.3x
Sat, 26 Aug 2023UKĀ£270.2bUKĀ£84.5bUKĀ£10.2b40.4x26.5x3.2x
Mon, 24 Jul 2023UKĀ£273.7bUKĀ£82.1bUKĀ£7.8b46.6x34.9x3.3x
Wed, 21 Jun 2023UKĀ£285.0bUKĀ£82.4bUKĀ£7.9b46.9x36.2x3.5x
Fri, 19 May 2023UKĀ£293.7bUKĀ£83.6bUKĀ£8.0b46.7x36.8x3.5x
Sun, 16 Apr 2023UKĀ£295.7bUKĀ£84.3bUKĀ£6.9b46.4x42.8x3.5x
Tue, 14 Mar 2023UKĀ£268.8bUKĀ£85.1bUKĀ£6.9b41.3x38.8x3.2x
Thu, 09 Feb 2023UKĀ£278.7bUKĀ£86.0bUKĀ£6.6b36.8x42.3x3.2x
Sat, 07 Jan 2023UKĀ£291.4bUKĀ£95.3bUKĀ£6.6b36.5x44.1x3.1x
Mon, 05 Dec 2022UKĀ£280.6bUKĀ£94.6bUKĀ£6.6b36.9x42.6x3x
Wed, 02 Nov 2022UKĀ£266.0bUKĀ£95.5bUKĀ£4.0b30.2x66.4x2.8x
Fri, 30 Sep 2022UKĀ£252.8bUKĀ£97.4bUKĀ£4.0b27.9x63.4x2.6x
Sun, 28 Aug 2022UKĀ£281.3bUKĀ£93.9bUKĀ£4.1b35.4x68.7x3x
Tue, 26 Jul 2022UKĀ£288.9bUKĀ£89.9bUKĀ£4.9b33.2x58.7x3.2x
Thu, 23 Jun 2022UKĀ£294.6bUKĀ£88.9bUKĀ£5.0b34.8x59.3x3.3x
Sat, 21 May 2022UKĀ£302.3bUKĀ£88.2bUKĀ£5.0b28.1x60.6x3.4x
Mon, 18 Apr 2022UKĀ£308.8bUKĀ£81.2bUKĀ£5.1b35.8x60.4x3.8x
Wed, 16 Mar 2022UKĀ£279.6bUKĀ£81.2bUKĀ£5.1b31.2x55.2x3.4x
Fri, 11 Feb 2022UKĀ£276.3bUKĀ£75.9bUKĀ£6.1b32.9x45.4x3.6x
Sun, 09 Jan 2022UKĀ£277.2bUKĀ£75.3bUKĀ£6.0b31.9x46x3.7x
Tue, 07 Dec 2021UKĀ£274.2bUKĀ£76.0bUKĀ£6.1b30.4x45x3.6x
Thu, 04 Nov 2021UKĀ£294.3bUKĀ£72.5bUKĀ£7.7b30.1x38x4.1x
Sat, 02 Oct 2021UKĀ£270.7bUKĀ£72.3bUKĀ£7.9b32.8x34.4x3.7x
Mon, 30 Aug 2021UKĀ£274.5bUKĀ£71.4bUKĀ£7.9b33.7x35x3.8x
Tue, 06 Jul 2021UKĀ£251.2bUKĀ£71.2bUKĀ£7.8b37.9x32.2x3.5x
Fri, 09 Apr 2021UKĀ£217.4bUKĀ£68.8bUKĀ£8.7b33x25x3.2x
Thu, 31 Dec 2020UKĀ£219.9bUKĀ£69.8bUKĀ£8.1b43.6x27.1x3.2x
Price to Earnings Ratio

27.2x


Total Market Cap: UKĀ£224.7bTotal Earnings: UKĀ£8.3bTotal Revenue: UKĀ£70.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthcare Sector Price to Earnings3Y Average 43.4x202120222023
Current Industry PE
  • Investors are pessimistic on the British Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.6x which is lower than its 3-year average PE of 43.4x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 8.9% per year over the last three years.
  • Revenues for these companies have grown 6.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare sector?

GB Market0.38%
Healthcare0.20%
Life Sciences1.75%
Healthtech0.34%
Pharma0.32%
Medical Equipment0.26%
Healthcare Services-0.41%
Biotech-4.40%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 82.3x.
    • Analysts are expecting annual earnings growth of 27.2%, which is higher than its past year's earnings decline of 12.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 27% over the next 5 years.
  • This is better than its past earnings decline of 12% per year.
  • In contrast, the Healthtech industry is expected to see its earnings grow by 15% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GSK GSKUKĀ£14.360.9%
+UKĀ£830.9m
0.8%PE9.6x
AZN AstraZenecaUKĀ£101.980.2%
+UKĀ£280.2m
-8.8%PE34.1x
SN. Smith & NephewUKĀ£10.361.1%
+UKĀ£95.7m
-5.0%PE52.7x
ONT Oxford Nanopore TechnologiesUKĀ£1.931.8%
+UKĀ£30.7m
-29.8%PS10.2x
TSTL TristelUKĀ£4.608.9%
+UKĀ£17.8m
27.8%PE48.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

HCM

UKĀ£2.90

HUTCHMED (China)

7D

-3.3%

1Y

28.0%

AZN

UKĀ£101.98

AstraZeneca

7D

0.2%

1Y

-8.8%

GSK

UKĀ£14.36

GSK

7D

0.9%

1Y

0.8%

GNS

UKĀ£19.09

Genus

7D

-8.7%

1Y

-36.8%

INDV

UKĀ£13.00

Indivior

7D

-0.6%

1Y

-24.4%

TSTL

UKĀ£4.60

Tristel

7D

8.9%

1Y

27.8%

ERGO

UKĀ£13.46

Ergomed

7D

0.1%

1Y

3.5%

CTEC

UKĀ£2.26

ConvaTec Group

7D

-1.1%

1Y

-2.9%

PRTC

UKĀ£1.52

PureTech Health

7D

-6.2%

1Y

-48.3%

ONT

UKĀ£1.93

Oxford Nanopore Technologies

7D

1.8%

1Y

-29.8%

EMIS

UKĀ£19.20

EMIS Group

7D

0.1%

1Y

2.8%

AVCT

UKĀ£1.35

Avacta Group

7D

-3.6%

1Y

26.2%